StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bernstein SocGen's Thoughts on Abbvie (ABBV) Following APGE Acquisition
June 23, 2026 9:12 AM
Bernstein SocGen Group analyst Courtney Breen reiterated a Market Perform rating and $225.00 price target on Abbvie (NYSE: ABBV).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
